Bellerophon Therapeutics Inc expected to post a loss of 42 cents a share - Earnings Preview
* Bellerophon Therapeutics Inc BLPH.OQ BLPH.O is
expected
to show no change in quarterly revenue when it reports
results on August 14 (estimated).
*
* Refinitiv's mean analyst estimate for Bellerophon
Therapeutics
Inc is for a loss of 42 cents per share.
* The one available analyst rating on the shares is
"hold".
* The mean earnings estimate of analysts was unchanged in
the last
three months.
This summary was machine generated August 11 at 15:05 GMT. All
figures in US dollars unless otherwise stated
Recent news on Bellerophon Therapeutics
See all newsBrief: Bellerophon Therapeutics Inc On October 12, 2023, Board Of Directors Approved Plan Of Liquidation And Dissolution Of Company
Bellerophon Therapeutics Inc reports results for the quarter ended in June - Earnings Summary
Bellerophon Therapeutics Inc expected to post a loss of 42 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Archer-Daniels-Midland, Nucor, Copper miners
U.S. STOCKS ON THE MOVE-Hubbell, Spire Global, FibroGen